Logo 1.png
Aeterna Zentaris Secures New European Patent Related to Use of Macimorelin for the Diagnosis of Growth Hormone Deficiency in Adults
19 avr. 2022 08h05 HE | Aeterna Zentaris Inc
– Strengthens intellectual property portfolio for macimorelin and the commercial product Ghryvelin® / Macrilen™ in Europe as the Company plans to pursue even greater protection TORONTO, ONTARIO,...
logo.png
Adhera Receives European Patent Covering MLR-1019 and Derivatives for Treating Dyskinesias
04 oct. 2021 09h15 HE | Adhera Therapeutics, Inc.
Baton Rouge, LA, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCPK: ATRX) ("Adhera" or the "Company"), a clinical stage biopharmaceutical company, is pleased to announce that a new...
logo.png
CGE Energy Granted Sixth Patent for Innovative Wind Turbine
24 nov. 2020 07h30 HE | CGE ENERGY, INC.
BRIGHTON, Mich, Nov. 24, 2020 (GLOBE NEWSWIRE) -- CGE Energy, Inc. (OTCPink: CGEI) is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No....
IMC Logo.jpg
Immuron Announces it has Received a European Patent Grant for NASH treatment
24 juil. 2018 06h30 HE | Immuron Limited
MELBOURNE, Australia, July 24, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ:IMRN) is an Australian microbiome biopharmaceutical Company focused on developing and commercializing orally...
Mount Tam Biotechnologies Announces that the European Patent Office Has Allowed a Key Patent for Lead Compound TAM-01
22 févr. 2018 09h00 HE | Mount Tam Biotechnologies Inc.
NOVATO, CA , Feb. 22, 2018 (GLOBE NEWSWIRE) -- Mount Tam Biotechnologies, Inc. ("Mount Tam") (OTC PINK: MNTM), a company focused on the discovery and development of novel mTOR inhibitors, is pleased...
AIMLogo.jpg
Hemispherx Biopharma Receives the European Patent Office Grant of New Composition of Matter Patent Covering Ampligen(R) Formulations
28 sept. 2015 08h30 HE | AIM ImmunoTech Inc.
PHILADELPHIA, Sept. 28, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced that it received formal notice on September 21, 2015, that the...